CytoDyn Starts Phase 2a Trial of Leronlimab in Early Alzheimer’s Disease
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
A phase 2a trial of leronlimab for the treatment of early alzheimer's disease has begun. The trial is being conducted by cytodyn. Leronlimab is being tested as a potential treatment for this condition.